PGs of the E series are involved in the control of LHRH secretion. The present experiments were conducted to clarify whether PGI 2 (prostacyclin) might be also involved in such a control, using multiple methodological approaches on immortalized LHRH-secreting neurons. A RT-PCR procedure to detect mouse PGI 2 receptor (IP) messenger RNA was first applied, and the results obtained showed the presence of a specific transcript in two cell lines of immortalized LHRH neurons (GT1-1 and GN11 cell lines possess the pharmacological characteristics of IP receptors. In functional studies, PGI 2 and its analogs, iloprost and cicaprost, were able to stimulate LHRH release from the GT1-1 cells with elevated potencies (EC 50 ϭ 0.6 -4.3 nM); PGE 1 was only slightly less active (EC 50 ϭ 28.5 nM), whereas PGE 2 , considered the major PG involved in LHRH secretion, was poorly effective (EC 50 ϭ 921 nM). The relative potencies (EC 50 ) of these compounds in stimulating the intracellular accumulation of cAMP were in line with their LHRH-releasing activities.
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In conclusion, these results indicate that immortalized LHRHsecreting neurons express IP receptors through which PGI 2 may exert relevant effects on LHRH release. (Endocrinology 140: [171] [172] [173] [174] [175] [176] [177] 1999) T HE PEPTIDE LHRH, synthesized by specific hypothalamic neurons, is the major regulator of the secretion of pituitary gonadotropins. The secretion of LHRH is under the control of multiple nervous pathways, which involve different neurotransmitters, several neuropeptides, steroid hormones, and other neuroactive factors (e.g. PGs, cytokines etc.) (1) (2) (3) .
The LHRH system is composed of only a few hundred neurons, which are not confined to a discrete nucleus but are distributed as clusters extending from the preoptic to the anterior hypothalamic regions (4) . Such an organization makes it difficult to determine, by in vivo or ex vivo experiments, whether the different regulatory factors exert their effects directly on the LHRH-synthesizing neurons or whether they act via the activation and/or inhibition of other neuronal systems impinging on the LHRH-secreting neurons (2) .
A promising tool for the investigation of the possible excitatory or inhibitory inputs reaching the LHRH-secreting neurons is represented by the utilization of immortalized hypothalamic cell lines, such as GT1 (5) and GN (6) cells. Among these, GT1 cells have been extensively studied, and it has been found that they retain many characteristics of hypothalamic LHRH-secreting neurons, such as a neuronal morphology, the expression of neuronal markers, an elevated synthesis of the LHRH gene, and the typical pulsatile secretion of LHRH (7) (8) (9) . In the last few years, the receptors for several families of neurotransmitters known to modify LHRH secretion have been identified on GT1 cells, and the stimulatory or inhibitory activity of the corresponding ligands on LHRH secretion has been documented (8) . In particular, the presence of functional opioid receptors of the ␦-type has been ascertained in GT1-1 cells, a subclone of the GT1 cell line (10) . It has also been reported that the activation of these receptors leads to an inhibition of the release of LHRH when this is stimulated by either forskolin or PGs (11) .
Prostanoids (PGs, tromboxanes, and leukotrienes), which derive from arachidonic acid metabolism, have been shown to affect reproductive functions (12) (13) (14) (15) . Among the various PGs, PGE 2 appears to be the one mainly involved in the control of LHRH secretion in vivo (16, 17) . PGE 2 is also able to induce a significant release of LHRH from GT1 cell line (11, 18, 19) , an effect accompanied by an increase in intracellular cAMP levels and probably mediated by the interaction with PG receptors of the EP series (see below) (20) . However, the involvement of PGE 1 in the control of the secretion of LHRH in vivo has also been reported (13, 21) , and previous results obtained in the authors' laboratory have shown that PGE 1 is more potent than PGE 2 in stimulating both LHRH release and cAMP accumulation in GT1-1 cells (10, 11) . According to the most recent classification of the PG receptors (22) , PGE 1 appears to interact with the putative PGI 2 receptor (IP receptor) with an affinity and a specificity higher than those found for any other member of the PG receptor family (e.g. EP).
The strong effect exerted by PGE 1 on the release of LHRH from GT1-1 cells supports the hypothesis that IP receptors might be present on these cells, and that their activation might influence the secretion of LHRH. This hypothesis has been verified by evaluating the expression of IP receptors in two immortalized LHRH neuronal cell lines (GT1-1 and GN11) using RT-PCR. Moreover, GT1-1 cells were used to perform specific binding assays for IP receptors and to measure the intracellular accumulation of cAMP and the release of LHRH after treatment with PGI 2 , its synthetic analogs iloprost and cicaprost, PGE 1 , and PGE 2 . 
Materials and Methods

Chemicals and reagents
Cell cultures
GT1-1 and GN11 cells were provided by R. I. Weiner (San Francisco, CA) and S. Radovick (Children's Hospital, Boston, MA), respectively. The cells were routinely grown in monolayer at 37 C in a humidified CO 2 incubator in DMEM containing 1 mm sodium pyruvate, 100 g/ml streptomycin, 100 U/ml penicillin, and 10 mg/liter phenol red and supplemented with 10% FBS. The medium was replaced at 2-day intervals. Subconfluent cells were routinely harvested by trypsinization and seeded in 57-cm 2 dishes (1 ϫ 10 6 cells). GT1-1 and GN11 cells within six passages were used throughout the experiments.
RT-PCR analysis
Expression of the specific messenger RNA (mRNA) coding for mouse IP receptors was tested after nucleic acid amplification, using a PCR procedure (RT-PCR), of reverse transcribed total RNA extracted from GT1-1 and GN11 cells. Cultured cells were solubilized in Ultra-Spect reagent (Biotex Laboratories, Inc., Houston, TX) and processed for total RNA extraction according to the protocol included in the reagent kit. RT and PCR were performed using a GeneAmp kit (Perkin Elmer, Branchburg, NJ) on 2 g total RNA from each sample. Samples of total RNA of adult mouse spleen, known to contain high levels of IP receptor mRNA (23), were obtained as described for the cells and used as positive controls. All of the synthetic oligonucleotides, obtained from Pharmacia Biotech (Uppsala, Sweden), were deduced from the complementary DNA (cDNA) sequence of the mouse IP receptor (GenBank accession no. D26157) and verified with the program Amplify (Bill Engels, University of Wisconsin, Madison, WI). The synthetic oligonucleotides used as primers were designed to amplify sequence 500-1128 of the IP cDNA, and their sequences were as follows: upstream primer, 5Ј-CAC. CCA.TCG.GCC.TTT.GCG.GT-3Ј; and downstream primer, 3Ј-TA. GTA.CCG.GCA.CAC.GAG.GGA-5Ј. To exclude the presence of contamination with genomic DNA, a parallel set of the RNA samples was assayed for RT-PCR, but reverse transcriptase was omitted from the incubation mixture.
The RT conditions were 42 C for 45 min, followed by 5 min at 95 C, using a final concentration of 1 mm of each deoxy-NTP, 1 U ribonuclease inhibitor, 2.5 U murine leukemia virus reverse transcriptase, and the downstream primer in a final volume of 20 l. The same buffer (50 mm KCl, 10 mm Tris-HCl, and 2 mm MgCl 2 ) was used for both transcription and amplification. After this step, 2.5 U Ampli-Taq polymerase and the upstream primer were added in a final volume of 100 l. Samples were amplified by repeated cycles (35 cycles) at 95 C for 1 min, followed by 1 min at 42 C and 1 min at 72 C.
Amplification products were separated by electrophoresis in 2% agarose gel and detected by ethidium bromide staining. The amplified cDNAs were transferred to blotting membrane (Hybond Nfp, Amersham) by capillary elution in 10 ϫ SSC (standard saline citrate) and fixed at 80 C for 2 h. A synthetic antisense oligonucleotide (3Ј-GC.AAG. GCG.GGT.CGG.ACC.GCC-5Ј complementary to the sequence 893-912 of IP cDNA) was used as radiolabeled probes in Southern analysis. The labeling reactions were performed at the free 5Ј-end of the oligoprimers using T4 DNA polynucleotide kinase, and [␥-32 P]deoxy-ATP. The cDNAs fixed on the membrane were incubated at 45 C for 4 h with a prehybridizing solution; after then, the 32 P 5Ј-end-labeled oligonucleotide probes (1 ϫ 10 6 cpm/ml) were added, and the hybridization reaction was left at 45 C for 16 h. After high stringency washes, the membranes were exposed to x-ray films (Hyperfilm, Amersham).
RT-PCR blanks were performed using distilled water instead of mRNA and simultaneously subjected to RT-PCR-Southern blotting with the same reagents and conditions described above; in any of the experiments performed, no specific signal could be obtained, indicating that no contamination by any reagent occurred in these studies. (24) was used to optimize the binding protocols, by selecting the lowest number of most appropriate concentrations. Homologous iloprost curves were always performed according to a mixed type protocol, combining both saturation (the first three concentration points of the curves, 1, 3, and 10 nm) and displacement (the last four concentration points, from 30 nm to 10 m) curves (25) . By effectively combining both saturation and competition protocols in a single curve, one can reach high concentrations of the ligand without consuming an excessive amount of labeled ligand (competition part of the curve), yet have adequate radioactivity in the lower concentration range (saturation part of the curve). Equilibrium binding studies were performed as previously described (26) 
Receptor binding assay
Static culture studies
GT1-1 cells were plated in 24-well plates (0.5 ϫ 10 6 cells/cm 2 ) and used after 5 days of culture. All of the samples were assayed for protein content using a microassay (27) with human serum albumin as a standard. No variations in total protein per well were detected in any of the experimental groups (data not shown).
On the day of the experiment, GT1-1 cells were washed with 1 ml DMEM (prewarmed at 37 C) before addition of the compounds to be tested, made from 1000-fold concentrated ethanolic solution.
cAMP accumulation. GT1-1 cells were preincubated for 15 min at 37 C in DMEM containing the phosphodiesterase inhibitor IBMX (0.5 mm). Intracellular cAMP accumulation was then measured over a 15-min incubation period at 37 C in DMEM with the various compounds in the presence of IBMX using a commercial assay kit (Amersham) after ethanolic extraction.
LHRH secretion. GT1-1 cells were incubated for 30 min at 37 C in DMEM with the test compounds. At the end of the incubation period the incubation medium was collected and centrifuged for 5 min at 12,000 rpm, and the supernatant was stored at Ϫ70 C until RIA. The content of LHRH in the culture medium was determined by RIA using a commercial antibody (L-8391, Sigma Chemical Co.) and iodinated LHRH (Amersham). Synthetic LHRH (NovaBiochem, Laufefingen, Switzerland) was used as standard. All samples from the same experiment were run in duplicate in the same assay. Inter-and intraassay variations were 9.4% and 6.6%, respectively. The sensitivity of the assay was 3.9 pg/ml.
Data analysis and statistical evaluation
Analysis of equilibrium ligand binding data were performed by means of the computer program Ligand (28) . Statistical analysis of the concentration-response curves was performed using the program Allfit (29) , which calculates the lower and upper plateaux, the slope, and the EC 50 and allows the comparison of two or more curves. Selection of the best fitting model and evaluation of the statistical significance of the parameters were based on the F test for the extra sum of square principle. A statistical level of significance with P Ͻ 0.05 was accepted. All curves shown were computer generated.
Results
RT-PCR analysis of the IP receptor transcript in immortalized LHRH-secreting neurons
The presence of a specific transcript for the IP receptor was initially investigated in GT1-1 and GN11 immortalized LHRH-secreting neurons. Figure 1 shows the autoradiographic data obtained after Southern analysis performed on the amplification products of the RT-PCR. Lane 1 corresponds to an internal control, in which no RNA was added to the PCR incubation mixture. The presence of a specific transcript of the expected size (628 bp) was detectable in RNA samples obtained from mouse spleen (lane 2), which was used as the positive control (23) . The results also show that a specific amplification of a transcript for the IP receptor was detected in both GT1-1 (lane 3) and GN11 (lane 4) cells; no amplification fragments were obtained from RNA samples when the incubation with RT was omitted (lanes 5 and 6), a fact that excludes contamination of the samples with genomic DNA.
Further assessment of the biological role(s) of the presence of IP receptors on immortalized LHRH-secreting neurons was performed using GT1-1 cells, because these cells represent a more mature form of LHRH neurons than GN11 cells, which show low levels of expression and release of LHRH. In addition, many aspect of the physiology of the GT1 cells have been widely characterized (8) .
Specific binding of [ 3 H]iloprost to GT1-1 cell membrane preparations
Binding experiments were then performed on GT1-1 cell membrane preparations using the stable PGI 2 2 and its analogs on GT1-1 cell membrane preparations.
Effects of different PGs on intracellular accumulation of cAMP in GT1-1 cells
It has been extensively reported that IP receptors are positively coupled to adenylate cyclase, and that PGI 2 strongly stimulates cAMP formation in neural cells (30) . A series of experiments were then performed to verify the effects of different PGs on the accumulation of intracellular cAMP in GT1-1 cells. In the experimental conditions adopted in the The dose-response curves obtained in these experiments are reported in Fig. 3 ; because of the differences observed in maximal responses (see below), the curves are represented as percent values. It has been found that PGI 2 as well as its synthetic agonists iloprost and cicaprost are similarly potent in stimulating cAMP accumulation in GT1-1 cells and more potent than PGE 1 and PGE 2 . The potencies of the different substances are reported in Table 2 ; it is evident that iloprost induces a sustained accumulation of cAMP with an EC 50 of 0.48 nm; PGI 2 and its other stable analog cicaprost are slightly less potent and stimulate cAMP formation with similar potencies (EC 50 1.08 and 1.28 nm, respectively). PGE 1 and PGE 2 are far less potent than PGI 2 , with EC 50 , of 46.8 and 1216.8 nm. Table 2 also shows that the compounds under study exert different maximal responses on cAMP formation. This parameter corresponds to the response at the "infinite" dose of each compound, as calculated by the Allfit program using absolute values. Iloprost appears to be the most efficient agent, inducing a 49-fold accumulation of cAMP over basal levels. PGI 2 and cicaprost show similar elevated maximal activities (33-and 38-fold, respectively). PGE 1 and PGE 2 possess an efficiency significantly lower than those of PGI 2 and its analogs, showing a maximal cAMP increase corresponding, respectively, to 21 and 8 times the basal levels.
Effects of different PGs on secretion of LHRH from GT1-1 cells
To verify whether the activation of cAMP-mediated intracellular pathways elicited by agents stimulating the IP receptor plays a physiological role in GT1-1 cells, the effects of various PGs on the release of LHRH were subsequently investigated. The results are summarized in Fig. 4 and Table  3 . The evaluation of LHRH accumulation in the culture medium under the effects of different PGs shows that cicaprost exerts the highest potency as an LHRH secretagogue (EC 50 ϭ 0.6 nm), followed by iloprost and PGI 2 , which are able to stimulate LHRH release from GT1-1 cells with similar potencies (EC 50 ϭ 4.3-4.7 nm). PGE 1 is less potent than PGI 2 and its stable analogs (EC 50 ϭ 28.5); PGE 2 shows the lowest potency (215 times less than that of PGI 2 ; EC 50 ϭ 921 nm). The maximal stimulation of LHRH release evoked by the various PGs is comparable and equivalent to an increase of 1-to 1.5-fold the basal levels measured in the medium of unstimulated cells (Table 3) .
Discussion
The present study provides the first evidence of the presence of specific prostacyclin receptors (IP receptors) on immortalized hypothalamic LHRH-producing neurons. The results reported here also show the presence of a specific transcript related to a sequence of the cloned mouse IP receptor (23) in two different cell lines of LHRH neurons, GT1-1 and GN11 cells. The presence of an IP transcript in both cell lines suggests that the expression of IP receptors is conserved among LHRH-secreting neurons and strongly supports the possibility that hypothalamic LHRH neurons in situ might also express IP receptors.
The experiments devoted to the clarification of the binding characteristics of the IP receptors and their possible physiological roles were performed in GT1 cells, as many mechanisms controlling LHRH release have been well studied in this cell line (8, 31, 32) . Values are expressed as the mean Ϯ SD. a cAMP levels obtained at the "infinite" dose of each compound and corresponding to the upper plateau of the dose-response curve obtained using absolute values.
b P Ͻ 0.05, significant vs. PGI 2 by Allfit analysis. (22, 23) . It is well known that IP receptors are positively coupled to adenylyl cyclase and that their activation leads to an accumulation of cAMP in several cells and tissues (37) . The results presented have clearly shown that PGI 2 and its analogs, iloprost and cicaprost, are strong stimulators of cAMP accumulation in GT1-1 cells, whereas PGE 2 possesses the lower potency. These data are consistent with previous findings showing that prostacyclin stimulates the intracellular accumulation of cAMP in nonneural and neural cells (23, 30, 38) and indicate, in addition, that this effect is induced via the activation of IP receptors.
The low efficacy of PGE 2 on cAMP accumulation was surprising in view of the preliminary identifications in GT1-1 cells of transcripts for the EP1, EP2, and EP3 PG receptors (20) to which PGE 2 preferentially binds (22) . However, the presence of biologically active receptors of the EP series in GT1-1
cells has yet to be demonstrated by functional or binding experiments.
The functional role of IP receptors detected on GT1-1 cells has been further confirmed in the present study by the finding that prostacyclin and its analogs stimulate the release of LHRH in a dose-dependent manner. In general, this effect reflects the pharmacological profile of the activation of the IP receptors as measured in the other experiments here described (e.g. binding studies and cAMP accumulation). However, even though there is a good correlation between the potencies (EC 50 ) and the efficacies of the various PGs in stimulating cAMP production, this is less evident when cAMP production and LHRH release are analyzed. First, PGI 2 , iloprost, and cicaprost stimulated cAMP accumulation with similar potencies; however, the latter compound proved to be much more potent than PGI 2 and iloprost in stimulating LHRH release. In this context, it is important to remember that the release of LHRH from GT1 cells is under the control of various signaling pathways and that each of these may operate via multiple steps (PKA, PKC, cGMP, ion channels, etc.) (8, 31, 32) . It has also been reported that PGE 2 -stimulated LHRH release involves intracellular calcium (39) . Because of these considerations, the apparent divergence in the potencies of cicaprost on cAMP accumulation and LHRH release may be indicative of the activation of signaling systems, other than cAMP (40), induced by cicaprost in GT1-1 cells.
Another point that deserves some comment is the fact that the PGs considered in the present study stimulate cAMP accumulation with different efficacies even if all of the compounds tested show similar maximal LHRH-releasing activity. One possible explanation of this quantitative discrepancy may be that the increase in intracellular levels of cAMP induced by the less effective agent (i.e. PGE 2 ) is already sufficient to totally discharge the pool of releasable LHRH present in GT1-1 cells. On the other hand, the elevated formation of cAMP induced by PGI 2 and its analogs might subserve additional cellular functions [for instance, the morphological differentiation of the cells we observed in preliminary experiments (Maggi, R., et al., in preparation)].
If one accepts that immortalized hypothalamic neurons represent a good model for study of the physiological functions of LHRH-producing neurons (8, 9) , the obvious conclusion derived from these results is that the selective activation of IP receptors (by PGI 2 or by PGE 1 ) may play an important role in the control of LHRH secretion.
The physiological relevance of the presence of IP receptors in and around the LHRH neuronal system is supported by the identification of similar amounts of PGE 2 and 6-cheto-PGF 1␣ , the main metabolite of PGI 2 , in extracts of rat median eminence (41). In addition, it has been reported that estrogens may affect the production of PGI 2 in different in vivo and in vitro systems (42).
The data reported here do not permit identification of the possible source of the PGI 2 interacting with the IP receptors present on hypothalamic LHRH neurons; nevertheless, some hypotheses may be proposed. The first takes into consideration a possible autocrine function of PGI 2 . It has been found that LHRH-liberating agents (e.g. endothelin) facilitate the release of LHRH from GT1 cells via stimulation of the pro -FIG. 4 . Dose-related effect of PGI 2 (OE), its synthetic analogs iloprost (F) and cicaprost (छ), PGE 1 (‚), and PGE 2 (E) on the release of LHRH from GT1-1 cells. Cells were incubated for 30 min with PGs, and the content of LHRH released in the culture medium was measured by RIA. Results are expressed as a percentage of the maximal effect obtained from each compound determined from three independent experiments using quadruplicate wells for each determination. (18, 45) . It is then attractive to hypothesize that PGI 2 , which is also produced by the vascular endothelium, might create an additional functional link between the portal vessels and the hypophysiotropic neurons, leading to a synergizing effect.
In conclusion, the present results indicate that not only PGE 2 , but also PGs acting on the IP receptors, may participate in the activation of LHRH release. As it is known that PGs represent the final mediator in many biological systems, the present results prompt additional studies on the reciprocal interactions between the most classical neurotransmitter systems known to induce the release of LHRH (norepinephrine, epinephrine, dopamine, nitric oxide, histamine, excitatory amino acids, etc.) and the ubiquitous system of arachidonic acid derivatives. 
